PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells

Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling

(2018) Wenwen Zhang et al.   FASEB JOURNAL

Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition

(2017) Mei Hua Jin et al.   MOLECULAR CANCER THERAPEUTICS

SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model

(2017) Feng Su et al.   ONCOLOGY REPORTS

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

(2017) Tatsuaki Takeda et al.   PLoS One

Erratum: Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer

(2017) Wei Song et al.   Scientific Reports

The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion

(2017) Narakorn Khunweeraphong et al.   Scientific Reports

The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer

(2016) Jiayan Luo et al.   International Journal of Biological Sciences

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

(2016) BO ZHOU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes

(2015) Elana J. Fertig et al.   Scientific Reports

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

(2014) Isabell Witzel et al.   OncoTargets and Therapy

Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin

(2013) Ann Gils et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells

(2012) M. Velasco-Velazquez et al.   CANCER RESEARCH

STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells

(2012) E. H. Yi et al.   MOLECULAR CANCER RESEARCH

CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma

(2012) Shih-Wei Wang et al.   PLoS One

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor-Positive Breast Cancer

(2011) E. L. Mayer et al.   CLINICAL CANCER RESEARCH

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition

(2011) B N Rexer et al.   ONCOGENE

Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis

(2009) Chih-Hsin Tang et al.   BIOCHEMICAL PHARMACOLOGY

Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant Tumors

(2009) Y. Chen et al.   CLINICAL CANCER RESEARCH

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

(2009) D. Mitra et al.   MOLECULAR CANCER THERAPEUTICS

CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways

(2008) Chun-Yin Huang et al.   BIOCHEMICAL PHARMACOLOGY